E3 PreliminaryPreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis.
Fostel, Jennifer, Boneva, Roumiana, Lloyd, Andrew · Pharmacogenomics · 2006 · DOI
Quick Summary
Researchers used blood tests and symptom questionnaires to look for biological markers that could help identify ME/CFS. They found that ME/CFS involves multiple symptom patterns (fatigue and mood changes being most prominent) and identified 57 genes whose activity differed between people with severe symptoms and those with mild symptoms. However, no single gene or blood test on its own clearly identifies the disease.
Why It Matters
This study addresses the critical need for objective biomarkers in ME/CFS, a disease often dismissed due to lack of measurable diagnostic tests. By integrating multiple data types (symptoms, genes, and laboratory parameters), it demonstrates that ME/CFS involves complex biological changes that cannot be reduced to single markers, informing future biomarker research strategies.
Observed Findings
- Four main symptom factors identified, with fatigue and mood disturbance being most prominent
- Fifty-seven genes showed differential expression patterns between patients with extreme symptom severity
- Gene expression patterns clustered with abnormalities in serum pH, electrolytes, glucose, liver enzymes, hematocrit, and white cell count
- Factor scores correlated with disability measures on the SF-36
- Significant gene expression separation occurred only at extremes of symptom severity (≤15th and ≥85th percentiles), not across the full spectrum
Inferred Conclusions
- ME/CFS is a multifactorial syndrome that cannot be characterized by individual laboratory tests or single gene expression changes
- The complex interplay between multiple symptom domains, gene expression patterns, and laboratory parameters suggests systemic involvement
- Analysis of integrated multifaceted datasets may be necessary to understand ME/CFS pathogenesis
Remaining Questions
- Which of the 57 identified genes play a functional role in ME/CFS, and which are merely correlated markers?
- Why do gene expression differences only appear at extremes of severity, and are there meaningful molecular differences across the full spectrum of disease?
What This Study Does Not Prove
This study does not establish causation or prove that the identified genes cause ME/CFS symptoms. It does not validate these gene signatures as diagnostic tests or show that changes in any single gene or laboratory parameter definitively indicate disease. The correlation with laboratory parameters does not explain whether these changes drive symptoms or result from the disease process.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:Gene ExpressionBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.2217/14622416.7.3.441
- PMID
- 16610954
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →